A Method For The Determination Of Noradrenaline At Normal Plasma Levels by Ambler, PK & Spicer, J
AJEBAK 58 (Pt. 2) 117-121 (1980)
© A METHOD FOR THE DETERMINATION OF
NORADRENALINE AT NORMAL PLASMA LEVELS
by P. K. AMBLER* AND J. SPICERf
(From the Department of Clinical Chemistry, Auckland Hospital, Auckland,
New Zealand*, and the Institute for Social Research, University of Michigan,
Michigan, U.S.A.f)
{Accepted for publication February 18, 1980.)
Summary. A detailed method for the determination of plasma levels of noradrenaline,
involving adsorption on to an alumina column, elution and formation of the noradreno-
lutine, is described. Particulars are also given of the preparation of the alumina, the
columns and the samples.
INTRODUCTION
Considerable evidence now indicates that individuals who exhibit certain
psychological characteristics experience significantly increased risk of coronary
heart disease (Jenkins, 1971 and Jenkins, 1976). The physiological and bio-
chemical mechanisms by which this increased risk is mediated are little under-
stood, though some promising directions for research are emerging (Dembroski,
MacDougall and Shields, 1977). Of particular interest is the pathogenic potential
of elevated catecholamine levels which may result in acute coronary events via
such mechanisms as myocardial necrosis due to electrolyte imbalance, ventricular
fibrillation or arterial spasm (Raab, 1966).
The plan of the experiment for which plasma catecholamine levels were
required is recorded elsewhere (Spicer, unpublished data). An attempt was made
to develop a method for determining plasma levels based on procedures reported
by Renzini, Brunori and Valori (1970), Wood and Mainwaring-Burton (1975),
Knight (1975) and Miura et al. (1977). Lack of sensitivity precluded the eventual
measurement of adrenaline at normal plasma levels. Although this same problem
affected assessment of noradrenaline levels below 1 nmol/1, a workable method for
measurement of this compound was achieved.
MATERIALS AND METHODS
Glass-distilled water deionised using Milli Q apparatus (Millipore Corp., Bedford, Massachusetts)
was used for all solutions unless otherwise stated. The Milli Q system was housed in a cool room at 4'
and a timer switch used to circulate the water for 3 min every hour.
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Before use, all glassware was acid-washed for at least 4 h in a 3 M hydrochloric acid-nitric acid
solution, then washed with both distilled and Milli Q water. All reagents were of Analar grade.
1I) Perchloric acid as a 4 M solution for protein precipitation.
(2) 5%di-sodiumEDTA.
(3) 10% sodium metabisulphite NajS^O,.
(4) 2 M hydrochloric acid made up in 1 litre lots for alumina preparation.
(5) Alumina (Merck)—standard grade.
(6) 002 M acetic acid and 0 2 M sodium acetate for alumina washing.
(7) Diphenol purple (ICN Pharmaceuticals) 0025% in 50% ethanol.
(8) L-Noradrenaline (L-Arterenol) (Sigma Chemical Co.).
(9) 10 M sodium hydroxide and 2 5 M sodium carbonate made up in 500 ml lots as required for
pH adjustment. Solution I is also used for this purpose.
(10) 0 3 M aeetic acid in 500 ml lots for use as an eluant.
(11) 0 002%cupricchlorideCuClj2HjO.
(12) Ferricyanide/borate solution. 0-015% potassium ferricyanide dissolved in 3 M sodium
tetraborate, Na2B4O,. Stable for one week stored in a dark bottle.
(13) 0-5% 2-mercaptoethanol (Merck). Prepared daily as a stock solution. From this a working
solution of 2-mercaptoethanol and 10 M sodium hydroxide in the ratio of4:l was prepared
just prior to starting the fluorimetric reaction.
(14) Glacial acetic acid.
A lumina preparation
500 g of alumina were washed at 80° with 2 M hydrochloric acid for 30 min using a plastic rod and
winged stirrer to minimise colloid formation. A period of 30 min was allowed for the alumina to settle,
the supernatant being discarded at the end of this time and the procedure repeated. This was followed by
10 min water washes and 5 niin settling periods until the pH of the supernatant had reached 3-5 to 4-0.
The alumina was then dried overnight in an oven at 100° and activated at 300' for 2 h.
Column preparation
11 cm X 1 -5 cm plastic test tubes (TVL) were used in a batch adsorption technique. 500 mg of
activated alumina were weighed into each and washed twice with 0-02 M acetic acid, three times with
water and four times with 0-2 M sodium acetate, each wash lasting 5 min. The purpose of this was to
remove all extraneous fme particles of alumina which would otherwise cause interference in the blanks
in the fmal reaction. The supernatant was discarded after every wash. Finally, I ml each of 0-2 M
sodium acetate and 5% di-sodium EDTA plus 100 /A of 0-25% diphenol purple was added to each tube.
These were then capped and stored ready for use.
Protein-free plasma preparation
1 ml of 4 M perchloric acid was added to approximately 35 ml of reconstituted freeze-dried plasma.
The mixture was stirred and centrifuged at 2000 rev./min for 20 min. The resulting supernatant was
separated off, re-spun and the fmal liquid phase stored at 4'. Further precipitation of fme colloidal
particles may occur at this temperature, so it is preferable to re-centrifuge rather than incur interference
in the fmal stages of analysis.
Freeze-dried plasma is prepared from blood collected in glass tubes containing no anti-oxidant. As
these conditions are conducive to fast noradrenaline decay, the level of noradrenaline in the freeze-dried
plasma, and hence the protein-free phase, was considered to be zero.
Sample collection
30 ml of blood were collected and immediately divided into three 10 ml aliquots which were placed
in separate 100 mm x 17 mm S4T plastic tubes (L.ab. Services, Auckland) containing 0-3 ml of 10%
sodium metabisulphite and 0-3 ml of 5% di-sodium EDTA. Each tube was capped, mixed by inversion
and placed in an ice-bath until centrifugation.
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The specimens were spun within 5 min and the plasma transferred to another tube containing 1 ml
of 4 M perchloric acid. The mixture was vortex mixed, centrifuged at 2000 rev./min for 10 min and the
resulting supernatant re-spun. The clear protein-free phase was frozen and stored for no more than 24 h
before analysis.
Standard preparation
(1) Stock solution: 50 mg of L-noradrenaline were dissolved in protein-free plasma and made up
to 100 ml. Stored at -20° this is stable for at least 3 months.
(2) Standard solutions; 0-1 ml of stock was diluted to 100 ml with protein-free plasma. 100, 50
and 25 fi\ of this solution were each diluted to 25 ml and a 25 /jl to 50 ml dilution was also made. These
four solutions are equivalent to 11-83, 5-91,2-96 and 1.48 nmoles/l(2,1,0 5 and 0.25 ng/ml) and were
prepared fresh on the day of analysis.
Adsorption andelution
5 ml of specimen were added to the prepared adsorption tubes. The pH at which catecholamines
are at their greatest percentage adsorption on alumina is 8 4 and alteration ofthe mixture to this was
made by addition of 10 M sodium hydroxide with fmal adjustment being done with 2 5 M sodium
carbonate or 4 M perchloric acid. At this point, the indicator colour should be just purple and should
remain so on shaking. Mixing was carried out for 5 min on a rotary Matbum mixer after which the
alumina was allowed to settle for about 30 sec and the supernatant aspirated off. Two successive washes
with 0 2 M sodium acetate (10 ml) and another two using 10 ml of Milli Q water were carried out. After
the fmal water wash the alumina was decanted as a suspension into 0-7 cm x 4 cm polythene columns
(Bio-Rad) fitted with a polyethylene sinter and a 10 ml reservoir. Vortex washing ofthe tubes with water
removed the remaining alumina.
The columns were drained using suction and centrifugation and the bottoms capped. 1 ml of 0 3 M
acetic acid was added to the column, the top sealed with parafilm "M" (American Can Co.) and the
whole vortexed for about 5 sec to obtain uniform dispersion. The columns were then rotary-mixed for 5
min, the tops and bottoms removed and the eluate centrifuged into 100 mm x 17 mm S4T plastic tubes
(Lab. Services Auckland) containing 0-1 ml 5% di-sodium EDTA. These solutions are reported to be
stable for up to 2 weeks at 4° (Renzini et al, 1970).
To remove any colloidal alumina which may have passed through the sinters it was necessary to
filter these solutions. Each solution was sucked into a 2 ml Summit syringe using a Terumo 25G1
disposable needle. The solution was then filtered through a 0 22 /i Millex filter (Millipore Corp.) into a
77 mm X 12 mm S3T tube (Lab. Services).
Fluorimetric reaction
All volumes were measured using Oxford micropipettes.
200 n\ from each noradrenaline solution was added to two acid-washed Brown cuvettes containing
10 ̂ 1 of 0 002% cupric chloride solution, one to be used as the test and the other as its corresponding
blank.
(a) Test reaction: 370 lA of 0-15% potassium ferricyanide solution was added at the start ofthe
time-reaction. This brought the solution to pH 6 5 at which oxidation of noradrenaline is favoured
(Laverty and Taylor, 1968). After 3 min 125 n\ ofthe 2-mercaptoethanol/sodium hydroxide solution
was added followed 5 min later by 20 jA of glacial acetic acid. The solution was vortex-mixed after each
addition.
(b) Blank reaction: A faded blank was prepared by adding 25 n\ of 10 M sodium hydroxide 3 min
after the ferricyanide solution. A 10 min interval was allowed to elapse after which time 100 n\ of water
followed immediately by 20 /J1 of glacial acetic acid were added.
Both solutions are quite stable at 4'.
The solutions were read fluorimetrically at excitation and emission wavelengths of 430 nm and 500
nm, respectively. Measurements were made using an Aminco-Bowman spectrofluorimeter fitted with a
xenon lamp and a R136 photomultiplier. Mirrors and 1 mm slits were placed in the cell housing. The
Brown cuvettes were blanked against a 5 cc quartz cuvette.
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RESULTS AND DISCUSSION
The method uses the principle outlined by Laverty and Taylor (1968) for the
specific oxidation of noradrenaline at pH 6-5. Interference from plasma adrena-
line levels at this pH is approximately 3% (Diamant and Byers, 1975) and is
considered to be negligible.
The accuracy of the method is dependent on systematic losses and experi-
mental error. It is essential that the time at which noradrenaline is at pH 8 4 is
kept to a minimum. Although this is the pH at which catecholamines are best
adsorbed on to alumina, it is also known that they auto-oxidise rapidly under
alkaline conditions (Weil-Malherbe, 1968). The presence of di-sodium EDTA in
the columns slowed this process allowing thorough washing ofthe alumina before
elution. If two water washes were not used fluctuation in pH was found on
addition of the 0 3 M acetic acid giving a variation in percentage elution. In the
method described the only variable error to this point was the amount of alumina
lost in transfer between the tubes and the columns and this was kept to a minimum
by water vortexing.
Renzini et al. (1970) suggested the addition of di-sodium EDTA stabilised the
eluate for 2 weeks at 4°. The addition was made but, as no indication was given as
to the stability at room temperature ofthe solution, it was considered necessary to
assay it as quickly as possible.
Removal of the colloidal alumina gave volume loss problems. Firstly, the
syringe failed to pick up all the eluant and, secondly, there was a 10% loss in the
ftltering apparatus. Although this caused no error in the quantitation procedure, it
limited the assay to only one set of test/blank specimens per sample. Increase in
the amount of eluant only decreased the concentration of catecholamines, and the
eluant concentration used, namely 0 3 M, gave the maximum percentage elution.
This was consistent with the fmdings of Wood and Mainwadng-Burton (1975) and
Knight (1975).
The method of analysis using the ferricyanide oxidation to noradrenolutine
was based on procedures outlined by Renzini et al. (1970) and Wood and
Mainwadng-Burton (1975). 2-mercaptoethanol was used as the stabilising agent
under alkaline conditions because it gave low blanks, was cheaper than related
mercapto-stabilising agents and gave no interaction with cupdc ions, the catalyst
in the oxidising step. Combined addition of 2-mercaptoethanol and sodium
hydroxide has long been known to give increased fluorescence (Weil-Malherbe,
1968). By bringing the final pH ofthe solution to pH 5 3 with glacial acetic acid,
the authors produced very stable conditions in which no fluorescence loss was
noted over 24 h. No precipitation of cupdc compounds occurred.
The major problem at the analysis stage was the matching of the Brown
cuvettes. Because of the low sensitivity at low levels, any scratch marks on the
cuvette caused vadations in the galvanometer readings. Cleanliness ofthe cuvettes
was also of maximum importance. With a matched set of acid-washed cuvettes the
authors achieved a precision of ± 6% including galvanometer error over a range of
lnmol/1 to a 10 nmol/1, the range over which lineadty of readings was also
achieved. The limit of sensitivity was taken to be that fluorescence which was
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twice that ofthe blank, and this occurred in the region of 1 nmol/1. This is below
the normal rangeof 18-4 1 nmol/1 for noradrenaline.
Interference from other substances structurally related to catecholamines can
affect the specificity of the results. Normetanephdne and metanephdne are not
adsorbed on to alumina and will therefore not interfere with this method. Other
chemically related compounds such as dopamine, tyrosine and their structural
cousins do not, in the main, form compounds which fluoresce at wavelengths near
500 nm when oxidised below pH 7. The only interfering compounds are
a-methylnoradrenaline which produces minimal fluorescence and L-dopa which
causes major interference.
The maximum number of specimens wbicb could be processed in a day from
adsorption to final calculation was 12. This does not include the time involved in
preparation of alumina and columns for which at least one day must be set aside.
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